Has Dennis Sanders, MD received payments from drug or device companies?

Yes. Drug and device makers reported $130 in general payments to Dennis Sanders, MD across 4 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dennis Sanders, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dennis Sanders, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dennis Sanders, MD

Medical Oncology · Colchester, VTNPI 1982603221

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $99 of the $130 with a category attached, or 76.4%. ASD Specialty Healthcare, LLC accounts for 66.3% of it on its own, with 2 other manufacturers making up the rest.

$130in general payments, 2019–2025

Across 4 payments — averaging $32.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ASD Specialty Healthcare, LLC$86
E.r. Squibb & Sons, L.L.C.$31
Sysmex America, Inc.$13

What the payments were for

Food & beverage$9976%
Education$3124%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ASD Specialty Healthcare, LLC	1	$86
E.r. Squibb & Sons, L.L.C.	2	$31
Sysmex America, Inc.	1	$13

How this compares

Too few medical oncology providers in Vermontto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024

$4,066,093

Medicare patients

524

Services billed

111,917

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ImbruvicaIbrutinib	42	$602,215
XtandiEnzalutamide	35	$594,892
TagrissoOsimertinib Mesylate	32	$422,699
CalquenceAcalabrutinib Maleate	21	$315,284
VerzenioAbemaciclib	19	$247,995
BraftoviEncorafenib	11	$167,042
NubeqaDarolutamide	12	$163,875
InlytaAxitinib	20	$150,411
Lenalidomide	14	$130,256
Abiraterone Acetate	36	$53,806
EliquisApixaban	75	$50,862
CotellicCobimetinib Fumarate	12	$48,583
MvasiBevacizumab-Awwb	14	$43,781
ZelborafVemurafenib	12	$19,755
Sunitinib Malate	12	$15,601

Paid to pharmacies, not to this prescriber.

Other medical oncology in Colchester

James GersonBurlington$22K
Randall HolcombeBurlington$21K
Mansour GergiBurlington$356
Sarah GillettBurlington$195
Shlomit Ein-GalBurlington$74
Asad AnwarBurlington$16
Marc GreenblattBurlington$15
Orion HowardBennington$11
Johannes NunninkBurlington$0
Heather WrightWhite River Junction$0

See the full list for Vermont →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →